AI clinical-trial patient recruitment
Machine-learning software that scans structured and unstructured electronic health records to identify patients meeting a clinical trial's eligibility criteria and to score candidate trial sites on live population data, replacing the manual chart review that has made patient recruitment the biggest bottleneck before a trial can even begin.
1 · What it gives
AI clinical-trial patient recruitment platforms scan structured and unstructured electronic health record data to identify patients meeting a trial’s eligibility criteria, replacing hours of manual chart review by clinical-research staff. Deep 6 AI optimizes site selection for clinical trials, letting sponsors base site choices on live population and screening data rather than historical site-performance metrics alone. TriNetX unveiled a conversational AI interface and enhanced API capabilities in January 2026, successfully reducing trial costs and timelines as part of platform enhancements designed to democratize clinical-research analytics. Antidote Technologies’ Antidote.me offers AI clinical-trial matching for physicians on an enterprise pay-for-performance model, connecting patients to research directly through referring clinicians. Mendel.ai’s software aims to save nurses time in pre-screening, and academic research on end-to-end AI-powered trial-recommendation systems (TrialMatchAI, published in Nature Communications 2026) explicitly frames patient recruitment as a major bottleneck calling for scalable, automated solutions — the problem this whole vendor category exists to solve. Paradigm Health’s AI-native solution increased screening capacity by 41% in an August 2026 partnership expanding clinical-trial access with Ochsner Health across the US Gulf South, and the company separately submitted a formal response to FDA’s Real-Time Clinical Trials Initiative RFI informed by biopharma sponsors and providers.
The key directions of AI clinical-trial patient recruitment are:
- EHR-based eligibility matching: scanning structured and unstructured patient records to automatically identify candidates meeting a trial’s specific eligibility criteria.
- Data-driven site selection: scoring candidate trial sites on live patient-population and screening data rather than relying on a site’s historical enrollment track record alone.
- Physician and patient-facing matching interfaces: conversational AI and referral tools that connect physicians and patients directly to relevant open trials.
- Screening-capacity expansion at health systems: deploying AI-native screening directly inside health-system workflows to expand the population that can be screened for trial eligibility.
Sectoral value chain#
[EHR data access & structuring] ──> [AI eligibility matching] ──> [Candidate patient shortlist]
│
(Site-selection scoring)
│
[Patient enrollment] <──── [Physician/patient outreach] <─── [Referring-clinician connection]
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| EHR data access & structuring | Accessing and structuring a health system’s structured and unstructured patient record data for analysis. | In: Raw EHR data. Out: Structured, analyzable patient data. |
| AI eligibility matching | Applying AI models to identify patients matching a specific trial’s eligibility criteria. | In: Structured patient data, trial eligibility criteria. Out: Matched candidate list. |
| Candidate patient shortlist | Compiling the matched candidates into a shortlist for clinical-research staff review. | In: Matched candidate list. Out: Reviewed candidate shortlist. |
| Site-selection scoring | Scoring candidate trial sites on live population and screening data to inform sponsor site selection. | In: Aggregated population/screening data. Out: Site-selection score. |
| Referring-clinician connection | Connecting a matched patient to the trial through their referring physician. | In: Reviewed candidate shortlist. Out: Physician referral to trial. |
| Patient enrollment | Completing the enrollment process for the referred, eligible patient. | In: Physician referral to trial. Out: Enrolled trial participant. |
Cross-cutting technologies of the sector:
- AI patient-trial matching: machine-learning software that scans structured and unstructured EHR data to identify patients meeting a trial’s eligibility criteria, replacing manual chart review.
- Real-time trial site-selection analytics: analytics that score candidate trial sites on live patient-population and screening data, letting a sponsor pick sites likely to enroll quickly.
2 · What it replaces 0 · matched by industry
No graded substitution linked yet.
3 · How to implement 6 steps
- 1EHR data access and structuringThe platform accesses and structures a health system’s structured and unstructured patient record data for AI analysis.
- 2AI eligibility matchingData, software & automationAI models identify patients matching a specific trial’s eligibility criteria from the structured data.Who can do this step matched automaticallyIndia Glycols (NSE) India✓ GMP 7,500 MT/ industrial scale“Even the administrative processes are green, where IGL has adopted the latest SAP ERP (S/4 HANA 2023 version), Salesforce CRM, Industrial IOT & other tech solutions to drive …”163,050 tonnes“As the fundamental component of 5G deployment, optic fibre is critical to making Hong Kong a smart city and laying the groundwork for IoT.”Metso Finland“With completely new and redesigned software,”✓ GMP industrial scale“The two parties will conduct extensive cooperationin the fields of digital agriculture, intelligent breeding and planting,precision feeding, manure treatment, animal disease …”MIRAI Japanindustrial scale“It also runs IoT/“SensorCorpus” software for monitoring/optimization, and its cultivation tech has been described as LED/water/airflow method optimization (e.g., “heavy lettuce”); …”
- 3Candidate patient shortlistMatched candidates are compiled into a shortlist for clinical-research staff review.
- 4Site-selection scoringCandidate trial sites are scored on live population and screening data to inform sponsor site-selection decisions.
- 5Referring-clinician connectionA matched, eligible patient is connected to the trial through their referring physician.
- 6Patient enrollmentThe enrollment process is completed for the referred, eligible patient, closing the loop from EHR data to enrolled participant.
4 · Who delivers
Matched suppliers (matched automatically)
| Fresenius | Germany | Producer | active |
| Scholar Rock | United States | Producer | active |
| Mindray | China | Producer | active |
| Altos Labs | United States | Research / RTO | active |
| Biohaven | United States | Research / RTO | active |
| Kirin Holdings | Japan | Producer | active |
| Recursion Pharmaceuticals | United States | Research / RTO | active |
| Genmab | Denmark | Producer | active |
| Boston Scientific | United States | Producer | active |
| Insilico Medicine | Cayman Islands | Producer | active |
| Meiji | Japan | Research / RTO | active |
In the services and supply catalogue 2 · paid service
LIMS / MES & lab informatics · Process modelling & simulation
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Deep 6 AI | 🇺🇸 USA | Site Selection platform | Live population/screening-data-based site scoring | commercial |
| TriNetX | 🇺🇸 USA | Conversational AI interface, enhanced APIs | Reduced trial costs and timelines (2026) | commercial |
| Antidote | 🇺🇸 USA | Antidote.me | Physician-facing AI matching, pay-for-performance | commercial |
| Mendel.ai | 🇺🇸 USA | Mendel.ai pre-screening software | Nurse pre-screening time savings | commercial |
| Paradigm Health | 🇺🇸 USA | AI-native screening platform | 41% screening-capacity increase at Ochsner Health | commercial |
5 · Rules & route to market
United States
The United States hosts the leading AI patient-recruitment vendors, several with direct 2026 health-system deployments and platform enhancements.
Deep 6 AI’s site-selection optimization, TriNetX’s conversational AI, Paradigm Health’s 41% screening-capacity gain#
- Deep 6 AI: optimizes clinical-trial site selection using live population and screening data rather than historical site performance alone.
- TriNetX: unveiled a conversational AI interface and enhanced API capabilities in January 2026, reducing trial costs and timelines as part of a broader effort to democratize clinical-research analytics.
- Antidote Technologies: its Antidote.me platform offers AI clinical-trial matching for physicians on an enterprise pay-for-performance model.
- Mendel.ai: its software aims to save nurses time in pre-screening, applying AI directly to the recruitment bottleneck that academic research has identified as the field’s central constraint.
- Paradigm Health: an August 2026 partnership with Ochsner Health increased screening capacity by 41% across the US Gulf South, and the company formally responded to FDA’s Real-Time Clinical Trials Initiative RFI.
European Union
No EU-headquartered vendor cleared the confirmation bar on this screen distinct from the US-headquartered platforms already tabled; European trial sponsors and health systems are served by the same global vendors listed above.
Served by the same global platforms rather than a distinct EU-headquartered specialist#
- EU deployment of global platforms: the vendors tabled above serve EU clinical-trial sponsors and health systems directly rather than through a confirmed distinct EU-headquartered competitor.
- No distinct EU-headquartered vendor confirmed: this screen did not surface an EU-headquartered AI patient-recruitment specialist distinct from the platforms already listed.
China
China is covered qualitatively rather than by a live-screened Chinese vendor: candidate Chinese AI patient-recruitment firms searched during this screen returned only generic market-research reports and academic commentary, not a confirmed named vendor, so no Chinese company is tabled below.
No confirmed named domestic vendor; market-research coverage describes the category rather than naming a leader#
- Market coverage without a named leader: Chinese-language sources describe the AI clinical-trial patient-recruitment market’s growth and trends extensively, but this screen did not surface a specific China-headquartered vendor confirmed by name in a live 2026 source.
- Domestic gap: no China-headquartered AI patient-recruitment platform confirmed by name was found during this screen.
6 · Money: tenders & grants
| Grant | NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) National Institutes of Health · United States | Jul 5, 2029 955 days |
| Grant | First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based … National Institutes of Health · United States | Oct 15, 2027 326 days |
| Grant | Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the … National Institutes of Health · United States | Aug 18, 2027 268 days |
| Grant | Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not … National Institutes of Health · United States | Jan 25, 2028 428 days |
| Grant | Health of ecosystems and wild species, predictions and impacts on human health, in the face of existing and … European Commission · EU | Sep 22, 2027 303 days |
7 · Tech stack & innovations
The AI clinical-trial patient recruitment technology stack combines EHR-scale data access with an increasingly conversational and health-system-embedded AI layer:
- Large-scale EHR data matching:
- Deep 6 AI and Mendel.ai apply AI directly to structured and unstructured EHR data to identify eligible patients without manual chart review.
- Conversational AI and API expansion:
- TriNetX’s January 2026 conversational AI interface and expanded APIs show the category moving toward more accessible, integration-friendly tooling.
- Health-system-embedded screening deployment:
- Paradigm Health’s direct partnership with a regional health system (Ochsner Health) demonstrates AI screening deployed inside clinical workflows rather than as a standalone research tool, delivering a measured 41% capacity gain.
Sources 5 · 0 independent · 5 producer sites
Producers' own sites 5
- Deep6ai producer checked 2026-05-25 · link not kept
- Trinetx producer checked 2026-07-15 · link not kept
- Antidote producer checked 2026-04-24 · link not kept
- Mendel ai producer checked 2026-05-25 · link not kept
- Paradigm health producer checked 2026-08-12 · link not kept